Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
29.36
+2.23 (8.22%)
At close: Dec 5, 2025, 4:00 PM EST
29.11
-0.25 (-0.85%)
After-hours: Dec 5, 2025, 7:56 PM EST
Terns Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
59
Market Cap
2.64B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TERN News
- 3 days ago - Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors - The Motley Fool
- 22 days ago - Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 26 days ago - Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 weeks ago - Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 4 weeks ago - Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades - Benzinga
- 4 weeks ago - Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting - GlobeNewsWire
- 6 weeks ago - Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data? - Benzinga
- 6 weeks ago - Terns Pharma ends obesity drug program after mid-stage trial data - Reuters